Under construction – not a live service
Sign in
Taking people in GermanyNo phase

Collects clinical data from people with heart attacks involving ST elevation

Observes people with a serious heart attack to collect clinical data over time.

Plain-language title generated from the registry record
Registry title: Systemic Organ Communication in STEMI

Key facts

Where
Düsseldorf, GermanySee the site

AI summary: who the study is looking for

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults who have had a ST-segment elevation myocardial infarction (STEMI), a serious type of heart attack. It collects clinical data from them.

Age
18 years or older
Sex
All sexes can join.
Disease stage
Patients suffering from STEMI.

Main reasons for not taking part

  • Younger than 18 years

Read by machine on 12 November 2026.

Where in Germany

  • Division of Cardiology, Pulmonary Disease and Vascular MedicineDüsseldorf, GermanyContact: Christian Jung, MD, PhDTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Heinrich-Heine University, Duesseldorf
Trial code
NCT03539133
Record updated
22 January 2026
Original description
Despite progress in pre-hospital care, ambulance logistics, pharmacotherapy and PPCI techniques, ST-segment elevation myocardial infarction (STEMI) continues to confer a substantial burden of morbidity and mortality.Read full original descriptionShow less

Systemic Organ Communication in STEMI

Despite progress in pre-hospital care, ambulance logistics, pharmacotherapy and PPCI techniques, ST-segment elevation myocardial infarction (STEMI) continues to confer a substantial burden of morbidity and mortality.

Within the STEMI population, there is a spectrum of higher and lower risk patients. The aim of this cohort study is to collect prospectively and systematically clinical research data from STEMI patients. This cohort study is an open-end observational study to identify master switches in myocardial ischemia.

Inclusion: Patients suffering from STEMI.

Exclusion: < 18 years.

ClinicalTrials.gov NCT03539133